Loading stock data…
TruBridge (TBRG)
$26.18-0.03 (-0.10%)
Market OpenUpdated 3:11 PM EDT
TruBridge, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
TruBridge, Inc. in the Healthcare sector is trading at $26.18 with a market capitalization of $392M. Wall Street consensus targets $25.44 (4 analysts), implying a -2.8% move over the next 12 months. The stock is currently near its 52-week high of $26.51, remaining 22.0% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $86.27M↓ | $87.79M↑ | $86.11M↑ | $85.73M↓ | $87.21M |
| Gross Profit | $47.92M↑ | $47.65M↑ | $44.06M↓ | $44.46M↓ | $47.70M |
| Operating Income | $3.06M↓ | $4.98M↑ | $4.07M↑ | $3.63M↓ | $8.16M |
| Net Income | $506,000↑ | -$4.29M↓ | $5.60M↑ | $2.58M↑ | $459,000 |
Peer Comparison
JNJUNHPFE
Fundamentals
TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in two segments, Financial Health and Patient Care. It offers rev...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$391.85M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
2.46%
Volume
Today's trading volume
322,472
Recent News
TruBridge TBRG Q4 2025 Earnings Transcript
Christopher Fowler: Thank you, John, and thank you, Dru, and thank you to everyone for joining us today to discuss our Full Year and Fourth Quarter. Total revenue for the quarter came in at $87.2 million, in line with the midpoint of the revised guidance we provided last quarter.
TBRG vs. Waystar: Which Healthcare RCM Stock Is the Better Bet Now?
WAY's AI-driven RCM growth and strong Q1 results stand out, while TruBridge trades near its pending buyout price with limited upside.
TBRG vs. PRVA: Which Stock Is the Better Value Option?
TBRG vs. PRVA: Which Stock Is the Better Value Option?
TBRG Posts Q1 Earnings: How to Play the Stock Amid Pending Sell-off?
TruBridge climbs after Q1 EPS beats estimates and an IKS Health buyout deal sets a $26.25-per-share cash offer for shareholders.
TBRG or PRVA: Which Is the Better Value Stock Right Now?
TBRG vs. PRVA: Which Stock Is the Better Value Option?